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Summary
Toll-like receptors (TLRs) are best known for their abil-
ity to recognize microbial or viral components and ini-
tiate innate immune responses. We showed here that
TLRs and their coreceptors were expressed by multi-
potential hematopoietic stem cells, whose cell cycle
entry was triggered by TLR ligation. TLR expression
also extended to some of the early hematopoietic pro-
genitors, although not the progenitor cells dedicated
to megakaryocyte and erythroid differentiation. TLR
signaling via the Myd88 adaptor protein drove differ-
entiation ofmyeloid progenitors, bypassing some nor-
mal growth and differentiation requirements, and also
drove lymphoid progenitors to become dendritic cells.
CD14 contributed to the efficiency of lipopolysaccha-
ride (LPS) recognition by stem and progenitor cells,
and LPS interacted directly with the TLR4/MD-2 com-
plex on these cells in bonemarrow. Thus, the preferen-
tial pathogen-mediated stimulation of myeloid differ-
entiation pathways may provide a means for rapid
replenishment of the innate immune system during
infection.
Introduction
The survival of an organism depends on an innate im-
mune system that can quickly recognize and respond
to microbial and viral products. Toll-like receptors
(TLRs) are responsible for much of that recognition
and consequently have vital roles in survival (Takeda
et al., 2003). Activation via TLRs couples innate immu-
nity with the adaptive immunity provided by lympho-
*Correspondence: kincade@omrf.ouhsc.educytes (Iwasaki and Medzhitov, 2004). Cells responsible
for both innate and adaptive immunity have finite life
spans and must be constantly replenished from hema-
topoietic stem cells (HSCs) and progenitors in bone
marrow (Kondo et al., 2003). Although TLRs on mature
immune cells have been well studied, little is known
about when maturing cells in bone marrow acquire func-
tional TLRs and whether those receptors influence he-
matopoietic development.
HSCs give rise to a series of progenitors that gradually
lose differentiation options and produce cells of a given
type. For example, multipotent progenitors (MPPs)
spawn common myeloid progenitors (CMPs) that give
rise to either megakaryocyte and erythrocyte progeni-
tors (MEPs) or granulocyte and macrophage progenitors
(GMPs) (Akashi et al., 2000). Early lymphoid progenitors
(ELPs) capable of producing T, B, and NK cells give rise
to prolymphocytes or common lymphoid progenitors
(CLPs) that can then become pre-B cells (Igarashi
et al., 2002; Kouro et al., 2002; Kondo et al., 1997). All in-
formation available to date indicates that commitment
to, and progression within, these lineages requires
well-studied growth and differentiation factors. These
and other extracellular cues control expression of key
transcription factors such as EBF, C/EBPa, and PU.1
(Henderson and Calame, 1998; Rosmarin et al., 2005).
There is considerable controversy concerning the
plasticity of stem cells and progenitors, and there are
numerous examples where lymphoid lineage cells
were experimentally converted to macrophages (Kondo
et al., 2000; Iwasaki-Arai et al., 2003; Xie et al., 2004). Al-
though there has been no physiological basis for this
phenomenon, it is interesting that plasmacytoid den-
dritic cells (DCs) can be converted to myeloid DCs dur-
ing viral infection (Zuniga et al., 2004).
The TLR family recognizes well-conserved microbial
and viral components. For example, TLR4 recognizes
bacterial lipopolysaccharide (LPS) from Gram-negative
bacteria (Hoshino et al., 1999), whereas TLR2 recog-
nizes peptidoglycan and lipoteichoic acid from Gram-
positive bacteria (Takeuchi et al., 1999). Effective stimu-
lation of cells via some TLRs requires cooperation with
other molecules. MD-2 is associated with TLR4 and is
essential for LPS recognition (Nagai et al., 2002). On B
lymphocytes, the RP105-MD-1 complex cooperates
with TLR2 and TLR4-MD-2 to cause antibody produc-
tion to microbial membranes (Nagai et al., 2005). How-
ever, unlike B cells, RP105 can be a negative regulator
of TLR4 signaling on macrophages (Divanovic et al.,
2005). CD14 is known to cooperate with TLR2 and the
TLR4-MD-2 complex in responses to lipoproteins and
LPS, respectively (Yoshimura et al., 1999; Means et al.,
1999). In addition, TLRs require intracellular adaptor
proteins for effective signaling. All TLRs except for
TLR3 use Myd88 for the production of inflammatory cy-
tokines (Takeda and Akira, 2005). In addition, TLR3 and
TLR4 use a Myd88-independent pathway, which is trig-
gered by the TRIF (also known as TICAM) protein critical
for induction of interferon-inducible genes (Yamamoto
et al., 2003; Oshiumi et al., 2003).
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microbial and viral products engage TLRs on innate im-
mune cells. For example, TLR2 and TLR4 are linked to
macrophage phagocytosis of bacteria (Blander and
Medzhitov, 2004). TLR signaling in DCs induces the ex-
pression of histocompatibility complex (MHC) and cos-
timulatory molecules as well as the production of IL-12,
a key cytokine for the induction of Th1 immune re-
sponses (Iwasaki and Medzhitov, 2004). In addition to
these well-studied examples involving mature cells,
there have been some hints that TLR might influence he-
matopoiesis. For example, chronic inflammation such
as that elicited with endotoxin alters myeloid/lymphoid
ratios in marrow (Ueda et al., 2004, 2005), and matura-
tion of osteoclasts is altered by TLR ligands (Sato
et al., 2004; Hayashi et al., 2003). Furthermore, although
the Toll pathway in Drosophila has a developmental role
in determining dorsoventral polarity (Ferrandon et al.,
2004), it could regulate hemocyte division and differen-
tiation in the steady state (Qiu et al., 1998).
We now report that early hematopoietic progenitor
cells expressed functional TLR2 and TLR4-MD-2.
When stimulated with TLR ligands in culture, myeloid
progenitors gave rise to monocytes and/or macro-
phages in the absence of exogenous growth and differ-
entiation factors, and lymphoid progenitors became
DCs. These results indicate that undifferentiated pro-
genitor cells can distinguish ‘‘non-self’’ from ‘‘self’’ via
TLRs and that microbial components could be cues for
hematopoietic cell development. Normally delivered
within the context of cytokines and chemokines, such
signals may help replace and/or increase cells that con-
stitute a first line of defense against pathogens.
Results
Toll-like Receptors and Associated Molecules Are
Expressed on Stem Cells and Early Hematopoietic
Progenitors
We wanted to determine when TLRs are acquired by
maturing hematopoietic progenitor cells, and whether
they have roles in hematopoiesis. Therefore, we traced
the expression of TLRs and their coreceptors on bone
marrow cells by flow cytometry. An initial finding was
that HSCs and early progenitors enriched in the lineage
marker-negative (Lin2) c-Kit+ subset, as well as mature
immune cells in the periphery, expressed TLRs and as-
sociated molecules. These included TLR2 and TLR4,
as well as MD-2 and CD14 (Figure S1A; see the Supple-
mental Data available with this article online).
Next, we divided Lin2 c-Kit+ cells into five major sub-
sets and evaluated them by flow cytometry (Figure 1A).
Gating and flow cytometry analysis of the progenitor
cells were performed as described by Kondo et al.
(2003) (see Method 1 in the Supplemental Data). The
HSC-enriched Lin2 IL-7Ra2 c-Kithi Sca-1+ fraction (here-
after referred to as LKS+) had uniformly high expression
of TLR2, and the same was true for Lin2 IL-7Ra+ c-Kitlo
Sca-1lo, prolymphocytes, or CLPs. Although this was
also the case for the Lin2 IL-7Ra2 c-Kithi Sca-12
(LKS2) fraction, CD342 FcgRlo MEPs within the LKS2
subset had very little TLR2 (Figure 1A). The Lin2 IL-
7Ra2 c-Kithi Sca-12 CD34+ FcgRhi GMPs subset was
uniformly TLR2+, and Lin2 IL-7Ra2 c-Kithi Sca-12CD34+ FcgRlo CMPs were heterogeneous with respect
to this receptor (Figure 1A). A new TLR4-specific anti-
body or one directed to the TLR4-MD-2 complex stained
the HSC-enriched fraction, and CD14 was also conspic-
uous. In contrast to HSCs, CLPs were very similar to
mature spleen B cells that have a high density of TLR2
and trace amounts of TLR4-MD-2 (Nagai et al., 2005).
TLR4 and CD14 were more easily seen on GMPs than
the two LKS2 companion subsets (Figure 1A).
Some TLRs are not displayed on the cell surface, so
each of the above-described fractions was analyzed
by RT-PCR (Figure 1B). In general, there was good cor-
relation between transcript expression and flow cytom-
etry results. Long-term repopulating HSCs are known to
be enriched in the Flk-22 subset of the LKS+ fraction
(Christensen and Weissman, 2001). Interestingly, this
Figure 1. TLRs and Related Molecules Are Expressed by Hemato-
poietic Stem Cells and Progenitor Cells
(A) Lineage marker-negative cells were enriched from bone marrow
suspensions before being stained with antibodies to hematopoietic
subsets and TLR2, TLR4, TLR4-MD-2, or CD14. Open histograms
depict staining with the appropriate isotype-matched Abs. The re-
sults shown are representative of three independent experiments.
(B) Total RNA was extracted from each progenitor subset, and semi-
quantitative RT-PCR was conducted to detect mRNA encoding
TLR4, MD-2, TLR2, and CD14. The results are shown as values nor-
malized to peak expression for each of the transcripts and are rep-
resentative of two independent experiments.
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803Figure 2. Activation of TLRs through Myd88 on LKS+ Cells Leads to Myeloid Cell Differentiation, and Stem Cell-Rich Flk-22 Cells Enter the Cell
Cycle with TLR Ligation
(A) (Left) Sorted LKS+ cells (10,000 cells/well) from C57BL/6 or Myd882/2 mice were cultured in the presence of FL and SCF with medium alone,
LPS (10 mg/ml), or Pam3CSK4 (1 mg/ml). After 72 hr in culture, cells were analyzed by flow cytometry for expression of lineage markers. Percent-
ages indicate the frequencies of Lin+ or Lin2 cells. (Right) The bar graph depicts yields, i.e., numbers of Lin+ cells recovered per input progenitor,
and the data represent mean values with standard deviations from triplicate cultures (*p < 0.01). The results are representative of five indepen-
dent experiments. Similar results were obtained when 1600, 5000, or 7500 LKS+ cells were plated per well (data not shown).
(B) Expression of CD45R/B220 or myeloid cell markers (Mac-1 and/or Gr-1) on cultured cells. The bar graph depicts percentages of recovered
cells bearing B220, CD11b/Mac-1, and/or Gr-1 lineage markers. Data represent mean values with standard deviations from triplicate cultures
(*p < 0.001). Similar results were obtained in three independent experiments.
(C) (Left) Sorted LKS+ cells (10,000 cells/well) from C57BL/6 mice were cultured in the presence of FL and SCF with medium alone, LPS (10 mg/ml),
or Pam3CSK4 (1 mg/ml). After 72 or 96 hr in culture, cells were analyzed by flow cytometry for Mac-1 and F4/80. (Right) The bar graph depicts cell
yields. Data represent mean values with standard deviations from triplicate cultures and are representative of three independent experiments
(*p < 0.002).
(D) Sorted Flk-22 LKS+ (10,000 cells/well) were cultured in the presence of SCF with medium alone, LPS (10 mg/ml), or Pam3CSK4 (1 mg/ml) for 50
hr and were pulsed with 10 mM BrdU for the final 18 hr. Cells were then stained with anti-BrdU. Percentages indicate the frequencies of BrdU+
cells, and the results are representative of three independent experiments.population had the highest expression of TLR2, TLR4,
and MD-2 mRNA, but little CD14. By flow cytometry
analysis, the Flk-22 and Flk-2+ subsets expressed simi-
lar densities of cell surface TLR2, TLR4-MD-2, and CD14
(Figure S1B).
The analysis was extended by staining progenitors
with antibodies to RP105 and MD-1 (Figures S2A and
S2B). Lin2 c-Kit+ progenitors in bone marrow expressed
the RP105-MD-1 complex, but the densities were less
than those found on mature cells. Among the progeni-
tors, RP105 was highest on CLPs detectable on GMPs
and was near background on the other subsets. The
density of MD-1 on most of these progenitors corre-
sponded with RP105 expression.
We conclude that some of the most primitive of hema-
topoietic progenitors in bone marrow, and especially
a rare stem cell-enriched fraction, express TLRs and
associated molecules.TLR Signaling Drives Myd88-Dependent Myeloid
Differentiation of Primitive Hematopoietic Cells
Our experiments then focused on potential functions for
TLRs on hematopoietic progenitors. We isolated LKS+
cells and stimulated them in serum-free, stromal cell-
free cultures with either LPS, a TLR4 ligand, or
Pam3CSK4, a ligand for TLR2. We determined in prelim-
inary experiments that the cytokines Flt-3 ligand (FL)
and Stem cell factor (SCF) promoted cell viability, but
alone caused little differentiation under these condi-
tions. The frequency of Lin+ cells increased as a result
of TLR stimulation in as little as 24 hr and progressed
with time (Figure 2A; Figure S3A). Absolute numbers of
Lin+ cells increased w8-fold within 72 hr, and this re-
sponse did not occur with cells from Myd88-deficient
mice (Figure 2A). To exclude the possibility that contam-
inated mature cells might respond to TLR ligands, the
number of LKS+ cells plated per well was reduced.
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were plated per well (data not shown). Expanding cells
expressed the Mac-1 and/or Gr-1 myeloid markers,
but not B220 (Figure 2B). The mature monocyte and
macrophage marker F4/80 was acquired by some cells
in as little as 72 hr, and levels increased dramatically
with time (Figure 2C). In parallel with these changes,
substantial numbers of LKS+ bone marrow cells ac-
quired FcgR in response to LPS or Pam3CSK4 exposure
within 24 hr (Figure S3B).
The dose of LPS required to stimulate hematopoietic
cells under serum-free conditions was high, and we
found minimal responses at concentrations below 10
mg/ml (Figure S3C). Serum is known to contain soluble
CD14, which enhances LPS and TLR2 ligand recognition
by mature cells (Yoshimura et al., 1999; Means et al.,
1999). Therefore, we added mouse CD14-Fc protein to
this culture system and found that it augmented the sen-
sitivity of LKS+ cells to LPS after 72 hr (Figures S3C and
S3D). That is, we recorded responses to as little as
0.1 mg/ml LPS and found coexpression of Mac-1 and
F4/80 within 72 hr (Figure S3D). A recombinant human
CD14 was similar to mouse CD14-Fc in augmenting
LPS responses (data not shown). Exogenous CD14 had
less influence on responses to Pam3CSK4 (Figure S3C).
Similar studies were performed with the LKS+ fraction
subdivided on the basis of Flk-2. The long-term repopu-
lating, stem cell-rich Flk-22 subset responded to TLR
stimulation, but it did so less dramatically than multipo-
tent Flk-2+ progenitors (Figure S3E). BrdU labeling ex-
periments showed that increased proportions of cells
stimulated with TLR ligands entered the cell cycle (Fig-
ure 2D). Thus, the quiescent long-term repopulating
HSC subset could be driven into the cycle by TLR
ligation.
A preliminary RT-PCR analysis was performed with
the same experimental design to verify TLR ligand-
induced differentiation (Figure S4). Transcripts for the
M-CSF receptor (c-fms) increased upon stimulation
with TLR ligands, consistent with monocyte and/or mac-
rophage differentiation, but the GM-CSF receptor was
highly expressed and unchanged. Another objective
was to determine if key transcription factors associated
with lineage fate decisions were altered. Depression of
SCL and GATA2 transcripts and a slight increase in
PU.1 were seen, as expected for myeloid progenitors
(Akashi et al., 2000). However, levels of the C/EBPa tran-
scription factor that can drive macrophage differentia-
tion (Rosmarin et al., 2005; Xie et al., 2004) declined
with TLR stimulation (Figure S4).
It is clear from these findings that two TLR ligands de-
livered Myd88-dependent signals, promoting myeloid
lineage progression of primitive hematopoietic cells.
Moreover, highly enriched populations of HSCs dis-
played functional receptors for these substances.
Signaling via TLRs on Granulocyte and Macrophage
Progenitors Obviates the Need for Growth
and Differentiation Factors
The above-described findings show that highly enriched
HSCs can be stimulated via TLRs to produce myeloid
lineage cells. We next asked if LKS2-committed myeloid
and erythroid progenitors would be similarly responsive.
Serum-free, stromal cell-free culture conditions wereused to determine whether the normal cues for differen-
tiation might be overcome. LKS2 cells responded to
TLR2 and TLR4 ligands and acquired F4/80 dramatically
(Figure 3A). Responses at 72 hr were indistinguishable
from those obtained when the same population was
stimulated with M-CSF. In contrast to the homogeneous
differentiation seen with those three stimuli, only a sub-
set of LKS2myeloid progenitors responded to GM-CSF.
Signaling via TLR, but not the CSFs, was dependent on
Myd88 (Figures 3A and 3B). In some experiments, yields
of F4/80+ cells obtained with LPS were nearly equal to
those derived with CSF stimulation, whereas Pam3CSK4
was consistently a less potent stimulus (Figure 3B).
When shorter culture intervals (24 or 48 hr) were used
to compare TLR and CSF receptor signaling (Figure S5),
TLR2 and TLR4 ligands caused much more rapid acqui-
sition of F4/80 than CSFs did.
It seemed possible that the hematopoietic cells were
induced to produce their own growth and differentiation
factors. Therefore, neutralizing monoclonal antibodies
to either an M-CSF receptor or GM-CSF were added to
the culture system (Figure 3C). Although the amounts
used were sufficient to completely block responses to
M-CSF, and greatly diminish those to GM-CSF, the anti-
bodies had no significant effect on TLR stimulation.
Three subsets of LKS2 cells were then sorted and
stimulated with TLR ligands (Figure 3D) to precisely
identify cellular targets for TLR stimulation. MEPs died
in culture, regardless of stimulus, and cells expressing
the erythrocyte-associated TER119 marker were never
recovered (data not shown). In contrast, GMPs pro-
duced F4/80+ cells within 24 hr (Figure 3D). Although
CMPs also produced F4/80+ cells, more time was re-
quired, and the calculated yield of F4/80+ cells at 72 hr
was less than one per input progenitor. These results
would be consistent with the lower expression of TLR2
and TLR4 on CMPs, and it seemed possible that some
of the CMPs can differentiate into even more TLR-
responsive GMPs in culture. Addition of exogenous
CD14 to this culture augmented stimulation via TLR2
and TLR4 (data not shown), but less than that described
above for stem cells.
We conclude that myeloid progenitors representing
a range of differentiation stages react to TLR ligands
via a Myd88-dependent pathway, and that GMPs repre-
sented the most TLR-responsive of myeloid progenitors
in bone marrow. There was no absolute requirement for
typical growth and differentiation factors under these
defined conditions of culture, and the responses were
distinct from those observed with CSFs both in terms
of time required and dependence on Myd88.
Monocyte and/or Macrophage Subsets Are Rapidly
Produced from Committed Myeloid Progenitors
after TLR Ligation
We wondered if a normal range of myeloid cell types
would be produced in response to TLR ligation. Accord-
ingly, GMPs were placed in defined culture conditions for
72 hr, and the recovered cells were evaluated (Figure 4).
In contrast to cultures stimulated with M-CSF or GM-
CSF, in which typical foamy macrophages or neutrophils
predominated, macrophage-like cells in LPS-containing
cultures had more basophilic cytoplasm with small
granules. Cells recovered from Pam3CSK4-stimulated
Toll-like Receptors Signal Hematopoietic Cells
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Myeloid Progenitors
(A) Sorted LKS2 cells from C57BL/6 or Myd882/2mice were stimulated with medium alone, LPS (10 mg/ml), Pam3CSK4 (1 mg/ml), M-CSF, or GM-
CSF. After 72 hr in culture, cells were analyzed by flow cytometry for expression of F4/80. Open histograms depict staining with the isotype-
matched Ab for F4/80. Percentages given in each histogram indicate the frequencies of F4/80+ cells, and the results are representative of three
independent experiments.
(B) The bar graph depicts yields, i.e., numbers of F4/80+ cells recovered per input progenitor. Data represent mean values with standard devi-
ations from triplicate cultures, and the results are representative of three independent experiments (*p < 0.005).
(C) Sorted LKS2 cells from C57BL/6 mice were stimulated with LPS (10 mg/ml), Pam3CSK4 (1 mg/ml), M-CSF, or GM-CSF in the presence of anti-
M-CSFR (10 mg/ml) or anti-GM-CSF (10 mg/ml). After 72 hr in culture, cells were analyzed by flow cytometry for expression of F4/80. Data
represent mean values with standard deviations from triplicate cultures, and the results are representative of three independent experiments
(*p < 0.01).
(D) (Left) Sorted CMPs or GMPs from C57BL/6 mice were stimulated with LPS (10 mg/ml) or Pam3CSK4 (1 mg/ml). After 24 or 48 hr in culture, cells
were analyzed by flow cytometry for expression of F4/80. Open histograms depict staining with the isotype-matched Abs for F4/80. Frequencies
of F4/80+ cells are given in each histogram, and the bar graphs on the right depict cell yields. The data represent mean values with standard
deviations from triplicate cultures and are representative of three independent experiments (*p < 0.02).cultures were less homogeneous in appearance (Fig-
ure 4A). Virtually all cells produced in response to LPS
or Pam3CSK4 expressed the Mac-1 marker, and the
staining intensities tended to correlate with densities
of F4/80 (Figure 4B). A conspicuous subset of Mac-1+
F4/802 cells seen in response to GM-CSF was not pres-
ent in TLR ligand-stimulated cultures. LPS was particu-
larly efficient in driving production of Mac-1hi F4/80hi
cells (Figure 4C). Previous studies showed that inflam-
matory Mac-1+ F4/80+ monocytes preferentially ex-
pressed Gr-1 and CD62L (Geissmann et al., 2003). This
inflammatory phenotype was observed for the Mac-1hiF4/80hi cells derived by TLR ligand or GM-CSF stimula-
tion, but not for the M-CSF-stimulated cells (Figure 4B).
The costimulatory CD86 molecule was present on TLR-
generated cells, but at lower expression than on cells in-
duced with M-CSF. Additionally, only 9% of the cells re-
covered from LPS-stimulated cultures after 72 hr, and
none from any of the other cultures, coexpressed the
Mac-1 and CD11c markers typical of DCs (data not
shown). These results indicate that TLR stimulation in-
duces committed myeloid progenitors to differentiate
into Mac-1hi F4/80hi monocytes and/or macrophages
with inflammatory characteristics. The phenomenon
Immunity
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tion of GMPs into F4/80hi Monocytes and/or
Macrophages
(A) These photomicrographs were prepared
with Giemsa-May-Gru¨nwald-stained cyto-
centrifuged slides.
(B and C) Sorted GMPs were stimulated with
LPS (1 mg/ml), Pam3CSK4 (100 ng/ml), M-
CSF, or GM-CSF. After 72 hr in culture, cells
were analyzed by flow cytometry for expres-
sion of F4/80 and Mac-1. Percentages indi-
cate the frequencies of Mac-1lo F4/80lo or
Mac-1hi F4/80hi cells. CD86, Gr-1, or CD62L
were analyzed by flow cytometry on Mac-1hi
F4/80hi cells. Open histograms depict stain-
ing with the appropriate isotype-matched
Abs. The results are representative of those
obtained in two independent experiments.
(C) The bar graphs depict cell yields of Mac-
1lo F4/80lo or Mac-1hi F4/80hi cells. The data
represent mean values with standard devia-
tions from triplicate cultures and are repre-
sentative of three independent experiments.may even be observed in the absence of exogenous
growth factors.
Preferential Dendritic Cell Differentiation of
Lymphoid Progenitors in Response to TLR Ligands
Under experimental conditions, CLPs can give rise to T,
B, NK, and DCs (Kouro et al., 2002, Kondo et al., 1997;
Karsunky et al., 2003; Shigematsu et al., 2004). Although
essentially pure populations of CD19+ B lineage cells
were produced from CLPs in serum-free, stromal cell-
free culture with cytokines (Figure 5A), only Mac-1+ cells
emerged when LPS was added. A mixture of the two cell
types was found in Pam3CSK4-containing cultures. This
dramatic change was dependent on Myd88, as only
CD19+ lymphocytes were produced when CLPs from
Myd88-deficient mice were stimulated. Most Mac-1+
cells had DC morphology on Giemsa-May-Gru¨nwald-
stained slides (Figure 5B). Further analysis of these
cultures revealed that almost all of the Mac-1+ cells pro-
duced from CLPs in response to LPS were CD11c+
Gr-12 (Figure 5C). Cells recovered from Pam3CSK4-con-
taining cultures were Gr-12, but were less homogenous.
Because CLPs express very little TLR4-MD-2 or CD14
(Figure 1), and the experiments described in Figure 5
were conducted with serum-free medium, exogenous
CD14 was added to the cultures to determine if thiswould influence efficiency of TLR4-MD-2 signals. The
addition of CD14 dramatically augmented DC produc-
tion by low doses of LPS in serum-free cultures, while
it had little effect on Pam3CSK4 responses (Figure 5D
and data not shown).
It seemed possible that TLR ligation induced produc-
tion of cytokines that could influence the differentiation
patterns we observed. GM-CSF and TNFa were of par-
ticular interest because they can promote the produc-
tion of DCs from bone marrow in vitro (Gilliet et al.,
2002), and TNFa can suppress B lymphopoiesis (Sedger
et al., 2002). However, we found that neutralizing anti-
bodies to either GM-CSF or TNFa did not inhibit the pro-
duction of DCs from CLPs induced by TLR ligands (data
not shown).
Although CLPs are largely B lineage restricted when
held in defined conditions, these progenitors produce
DCs in stromal cell cocultures and transplantation as-
says (Karsunky et al., 2003; Shigematsu et al., 2004). It
seemed possible that TLR ligation quickly substitutes
for that permissive signal and selects for clones that
are not fully B lineage committed. Therefore, CLPs
were sorted to high purity and incubated for 24 hr with
LPS, Pam3CSK4, or medium alone. Each group was
then harvested, and single cells were plated on OP9
stromal cells with cytokines to assess differentiation
Toll-like Receptors Signal Hematopoietic Cells
807Figure 5. TLR Stimulation Allows Lymphoid-Biased Progenitors to Produce Dendritic Cells at the Expense of B Lymphopoiesis
(A) Sorted CLPs (5000/well) from C57BL/6 or Myd882/2mice were stimulated in X-VIVO15 medium alone, LPS (10 mg/ml), or Pam3CSK4 (100 ng/
ml) plus SCF, FL, and IL-7. After 7 days in culture, cells were analyzed by flow cytometry for expression of CD19 and Mac-1 (Left). The bar graphs
depict cell yields for CD19+ cells or Mac-1+ cells (right), and the data represent mean values with standard deviations from triplicate cultures (*p <
0.02). The results are representative of those obtained in five independent experiments.
(B) Subsets of the recovered cells described in panel (A) were sorted and used to prepare Giemsa-May-Gru¨nwal-stained slides.
(C) Cultured cells from C57BL/6 mice were also analyzed by flow cytometry for expression of Gr-1 and CD11c.
(D) Sorted CLPs from C57BL/6 mice were cultured in the presence of SCF, FL, and IL-7 with a range of concentrations of LPS or combinations of
recombinant mouse CD14-Fc protein (1 mg/ml) plus LPS. After 7 days in culture, cells were analyzed by flow cytometry for expression of CD19
and Mac-1 (left). The bar graph depicts cell yields for CD19+ cells or Mac-1+ cells (right). Data represent mean values with standard deviations
from triplicate cultures (*p < 0.003). The results are representative of three independent experiments.potential (Figure 6). Four types of clones were detected
10 days later (pure CD19+ B lineage, pure CD11c+ single
positive, CD19+ plus CD11c+ mixed, or CD11c2 CD192
clones). Pure B lineage colonies were the largest in
size (data not shown). Most of the CD11c+ cells were
also Mac-1+, and CD11c+ single positive DC or mixed
colonies were very small (data not shown). Numbers of
pure B cell clones consistently declined when LPS was
present, while the same treatment increased numbers
of pure DC colonies. Pam3CSK4 also enhanced produc-
tion of colonies with pure DC, but did not alter the pro-
duction of CD19+ B cell clones. Thus, the results of these
clonal assays concur with those obtained with serum-
free, stromal-cell free bulk cultures.
RT-PCR was then used to evaluate CLPs 24 hr after
stimulation with TLR ligands (Figure S6). As might be ex-
pected with maturing DCs, transcripts corresponding to
GM-CSF receptors increased with stimulation. Reduc-tions were recorded in the EBF, E12, and RAG-1 tran-
scription factors required for lymphopoiesis, in parallel
with increases in M-CSF receptor, but changes in three
others, PU.1, E47, and Pax-5, were not remarkable. As
noted above for stem cells, levels of the C/EBPa tran-
scription factor actually declined after TLR ligation.
These results demonstrate that lymphoid-biased pro-
genitors can be driven to a DC fate by Myd88-dependent
TLR signals. Even though CLPs express little TLR4-MD-
2, LPS alters their differentiation with sufficient amounts
of CD14. TLR signals suppress B lymphopoiesis and
stimulate the dendritic potential of lymphoid-biased
progenitors.
Exposure to LPSModulates the TLR4-MD-2 Complex
on Hematopoietic Progenitor Cells In Vivo
The above-described results showed that highly purified
progenitors can respond to TLR ligands in defined
Immunity
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phenomena pertain to progenitors in the bone marrow.
LPS is known to cause a very rapid change in the
TLR4-MD-2 complex, and this LPS-specific conforma-
tional change results in diminished staining with a unique
TLR4-MD-2-specific mAb (Akashi et al., 2003). We ex-
ploited this phenomenon to ask if LPS can interact di-
rectly with hematopoietic progenitors in a physiological
setting. First, whole bone marrow cells were stimulated
with LPS in vitro and then stained with the mAb 1 hr later
(Figure 7, left). While untreated bone marrow cells were
clearly recognized by this mAb, staining for TLR4-MD-2
was essentially negative after just 1 hr of LPS exposure.
We then harvested bone marrow cells from wild-type
mice 1 hr after treatment with LPS or PBS (Figure 7,
right). Brief in vivo exposure to LPS completely abol-
ished TLR4-MD-2 staining on these progenitors.
Figure 6. Altered Differentiation Patterns of Single Lymphoid Pro-
genitors Activated via TLRs
Sorted CLPs were cultured in the presence of SCF, FL, and IL-7 with
medium alone, LPS (10 mg/ml), or Pam3CSK4 (1 mg/ml). After 24 hr,
cultured cells were harvested and washed three times with medium.
Single cultured cells were then sorted and recultured on OP9 stro-
mal cells in 96-well plates for 10 days in the presence of SCF, FL,
and IL-7. Positive colonies were examined by flow cytometry (repre-
sentative examples shown in the top row). The frequencies of wells
with each of these differentiation patterns are shown along with the
total numbers of clones observed.Bone marrow and spleens were then evaluated after
LPS injection to determine if this treatment caused per-
turbations in hematopoietic cells. As has been noted in
a previous study (Ueda et al., 2004), LPS depressed
numbers of newly formed AA4.1+ B220+ B lineage lym-
phocytes in the bone marrow (Figure S7A). Reciprocally,
numbers of Mac-1+ F4/80+ monocytes and/or macro-
phages increased in the bone marrow and spleen
(Figure S7B). Increases were also recorded in the num-
bers of Mac-1+ CD11c+ DCs in spleen (Figure S7C).
We conclude that hematopoietic progenitor cells
within bone marrow are directly and quickly affected
by exposure to this TLR ligand. Changes in hematopoi-
etic cells in vivo resemble the patterns of differentiation
seen under highly defined conditions of culture.
Discussion
A principal finding is that HSCs and some of their deriv-
ative-committed progenitors display functional TLR2
and TLR4-MD-2. The TLR4-MD-2 complex cooperates
with CD14 at the cell surface, and optimal responses
to LPS or a synthetic lipopeptide require Myd88. TLR li-
gation obviated some of the normal differentiation cues
and stimulated progenitors to become monocytes and/
or macrophages with inflammatory phenotypes. Addi-
tionally, lymphoid-biased progenitors were directed to
a DC fate in response to TLR signals. Members of the
TLR family may allow hematopoietic stem/progenitors
to directly sense microbial and viral products and alter
normal differentiation patterns. When integrated with
signals from cytokines and chemokines, this mecha-
nism could provide a means for boosting the innate
immune system during life-threatening infection.
A key question is how TLR signals stimulate hemato-
poietic cells to adopt a particular fate and diminish the
need for some cytokines. Progenitors from Myd88-defi-
cient mice were unresponsive to two TLR ligands, so at
least some of the previously described intracellular TLR
signaling pathways are used. The Myd88-independent
TRIF pathway, which contributes to production of type
I IFN (Yamamoto et al., 2003; Oshiumi et al., 2003), might
not be important to the responses we observed. TLRFigure 7. LPS Rapidly Changes the TLR4-MD-2 Complex on Hematopoietic Stem/Progenitors
(Left) Whole bone marrow cells from C57BL/6 mice were cultured with medium alone or LPS (1 mg/ml) for 1 hr. The cells were then harvested and
stained with mAbs to TLR4-MD-2, Mac-1, lineage markers as described in Experimental Procedures, Sca-1, and c-Kit. The MTS510 reagent
is unique in detecting a conformation-dependent epitope on TLR4-MD-2 (Akashi et al., 2003). Open histograms depict staining with the iso-
type-matched Ab for TLR4-MD-2. The results are representative of three independent experiments. (Right) C57BL/6 mice were intravenously
or intraperitoneally injected with PBS or 100 mg LPS from E. coli. After 1 hr, mice were sacrificed, and whole bone marrow cells were harvested
and stained with mAbs to TLR4-MD-2, Mac-1, lineage markers, Sca-1, and c-Kit. Open histograms depict staining with the isotype-matched Ab
for TLR4-MD-2. The results are representative of four independent experiments.
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transcripts while only slightly changing PU.1, but we
were surprised to find declines in the C/EBPa transcrip-
tion factor that can drive macrophage differentiation
(Rosmarin et al., 2005; Xie et al., 2004). Many of the other
transcription factor changes were consistent with in-
creased myeloid differentiation. We considered the pos-
sibility that TLR ligands might stimulate hematopoietic
cells to make their own factors. However, addition of
neutralizing antibodies to M-CSF, GM-CSF, or TNFa
provided no evidence for autocrine stimulation. Addi-
tional experiments are required to exclude the potential
contribution of other cytokines.
The results of stromal cell cocultures initiated with
a single CLP extend those obtained in bulk, stromal
cell-free cultures and would be consistent with either
of two possible interpretations. TLR ligands could sup-
press individual progenitors that are inherently biased
for lymphopoiesis while simultaneously stimulating
those destined to produce DCs. Alternatively, single
progenitors could be ‘‘reprogrammed’’ to adopt differ-
ent fates as a result of TLR stimulation (Xie et al., 2004).
HSCs divide infrequently under normal circum-
stances, and retention of their unique potential for self-
renewal may require residence in specialized niches
near the endosteal surface (Zhang et al., 2003). Such
an environment could protect the majority of stem cells
from systemic events that would have potentially delete-
rious effects. An additional expectation is that stem cells
express only those receptors needed to maintain their
quiescence or allow them to actively differentiate as
needed to replenish blood cell populations. Therefore,
finding that functional TLRs and associated molecules
are present at the stem cell stage was unexpected and
raises the possibility that TLR ligands influence numbers
and characteristics of stem cells in treated animals. Re-
peated infections could theoretically exhaust the self-re-
newal potential or have other long-term consequences
for the stem cell pool. Consequently, protective mecha-
nisms may have evolved to block this response. Several
negative regulators for TLR signaling have been re-
ported that might work in a cell type-dependent manner
(Liew et al., 2005). Furthermore, the RP105-MD-1 com-
plex can be a negative regulator of TLR4 signaling on
macrophages (Divanovic et al., 2005). It will therefore
be important to learn if signals delivered via inhibitory
molecules influence stem cell behavior. On the other
hand, recognition that functional TLRs are expressed
on progenitors may suggest new ways to manipulate
their activity for therapeutic purposes.
Curiously, HSCs are present in the circulation as well
as tissues such as skeletal muscle (Kawada and Ogawa,
2001). Since almost all blood cell formation occurs in
bone marrow, the biological significance of this distribu-
tion is unclear. It is attractive to consider that dispersed
stem cells sense foreign materials and become locally
converted to innate effector cells.
It is difficult to use surface TLR expression to predict
the efficiency of responsiveness to particular TLR li-
gands because many TLRs are intracellular, and core-
ceptor components could influence the avidity of recep-
tor-ligand interactions (Matsumoto et al., 2003; Latz
et al., 2004; Takeuchi et al., 2001, 2002). Despite high-
level display of TLR2, responses of hematopoietic pro-genitors to the TLR2 ligand lipopeptide were often
weaker than those to LPS. Responses of LKS and lym-
phoid progenitors to LPS in serum-free cultures were
significantly augmented by provision of soluble CD14,
but there was much less influence on lipopeptide re-
sponses. It will be important to study additional TLR li-
gands in the same way and learn if coreceptors can mod-
ulate the nature or magnitude of differentiation changes.
There is a huge body of literature concerning physio-
logical responses to bacterial components (Beutler
and Rietschel, 2003; Taylor, 2001). Multiple cell types re-
spond, various cell types are redistributed in the body,
cytokines are released, and the coagulation system is
activated. Dissecting discrete stimulatory pathways
and mechanisms is extremely difficult in those circum-
stances. However, mobilization and redistribution of
hematopoietic cells in response to inflammatory pro-
cesses has been known for some time (Ueda et al.,
2004, 2005). In our experiments, LPS injections depleted
B lineage lymphocytes from bone marrow, as previously
described by others (Ueda et al., 2004), and there were
corresponding increases in macrophages and DCs.
Multiple mechanisms may account for these changes,
but they are consistent with the responses of highly pu-
rified progenitors in defined culture conditions. The
TLR4-MD-2 complex undergoes a rapid change upon in-
teraction with LPS such that staining with the MTS510
mAb is abolished (Akashi et al., 2003). We exploited
this response to learn that injected LPS rapidly diffuses
into the bone marrow cavity and engages the receptors
of stem cells and progenitors. Thus, our findings sug-
gest that rapid interactions between foreign substances
and hematopoietic progenitors could occur in bone
marrow. Signals delivered via that mechanism would
be in addition to, and in context with, those associated
with cytokines and chemokines.
Our findings suggest that stem cells and progenitors
need to be investigated from the perspective of dis-
ease-related processes. As just one example, full matu-
ration of osteoclast progenitors is known to be altered
by ligation of TLRs on hematopoietic cells (Sato et al.,
2004; Hayashi et al., 2003). An imbalance of osteoclast
versus osteoblast activity and abnormal bone density
might result from chronic microbial and viral infections.
A report has just appeared that shows that human
CD34+ cord blood cells express functional TLR9 (Kim
et al., 2005). It is therefore important to learn if TLR-ex-
pressing hematopoietic cells are involved in pathoge-
netic mechanisms.
In addition to the importance of TLRs in sensing path-
ogen-associated molecular patterns, a number of en-
dogenous TLR ligands have been described (Tsan and
Gao, 2004). Experimental TLR-dependent responses to
these substances might have been due to trace contam-
ination with bacterial products. However, the innate
immune system could use this mechanism to sense
danger represented by inflamed or remodeled tissues
(Seong and Matzinger, 2004). There are no published de-
scriptions of hematopoietic maturational defects in TLR
gene targeted mice. This could reflect functional redun-
dancy among TLRs or indicate that hematopoietic cells
use these receptors only in response to infections.
The Toll receptor was first discovered because of its
importance to the establishment of dorsoventral polarity
Immunity
810inDrosophila embryos (Ferrandon et al., 2004). While the
best-known functions of TLRs in higher species involve
mature cells, our results indicate that self/non-self dis-
crimination may begin at the level of HSCs and progen-
itors. TLR signals could help to activate quiescent stem
cells and influence the types of cells they produce. This
may augment the capability for rapidly replenishing the
innate immune system during infection.
Experimental Procedures
Mice
C57BL/6 and Myd882/2 mice were used at 8–10 weeks of age.
C57BL/6 mice were purchased from the Jackson Laboratory (Bar
Harbor, ME). Myd882/2 mice were maintained in our laboratory an-
imal resource facility (LARC) at the Oklahoma Medical Research
Foundation.
Reagents
Recombinant mouse IL-7, stem cell factor (SCF), Flt-3 ligand (FL), M-
CSF, GM-CSF, recombinant mouse CD14/Fc chimera protein, and
recombinant human CD14 were purchased from R&D Systems (Min-
neapolis, MN). LPS from Escherichia coli 055:B5 was purchased
from Sigma-Aldrich (St. Louis, MO). A synthetic lipopeptide,
Pam3CSK4, was purchased from InvivoGen (San Diego, CA).
Antibodies and Flow Cytometry
The following antibodies for flow cytometry were purchased from
eBioscience (San Diego, CA): biotinylated anti-TLR2 (clone GC2), bio-
tinylated anti-TLR4-MD-2 (clone MTS510), biotinylated anti-RP105
(clone RP/14), biotinylated anti-MD-1 (clone MD113), biotinylated
anti-CD14 (clone Sa2-8), PE-conjugated anti-CD62L (clone MEL-
14), allophycocyanin (APC)-conjugated anti-F4/80 (clone BM8),
anti-c-Kit (clone ACK2), phycoerythrin (PE)-Cy5-conjugated anti-
Sca-1 (clone D7), biotinylated anti-Flk-2 (clone A2F10), purified
anti-mouse CD115 (CSF-1R, clone AFS98), purified anti-mouse
GM-CSF (clone MP1-22E9), and purified anti-mouse TNFa (clone
MP6-XT22).
The following antibodies for flow cytometry were purchased from
BD Pharmingen (San Diego, CA): FITC-conjugated anti-CD2 (clone
RM2-5), anti-CD33 (clone 145-2C11), anti-CD8a (clone 53-6.7),
anti-CD45R (B220; clone RA3-6B2), anti-Ly6G (clone RB6-8C5),
anti-CD11b/Mac-1 (clone M1/70), anti-TER119, anti-CD34 (clone
RAM34), anti-CD11c (clone HL3), PE-conjugated IL-7Ra (clone SB/
119), anti-CD19 (clone 1D3), anti-Ly6G (clone RB6-8C5), anti-
CD11c (clone HL3), anti-FcgR2/3 (clone 2.4G2), anti-AA4.1, anti-
CD86 (clone GL1), APC-conjugated anti-CD45R (clone RA3-6B2),
anti-CD11b/Mac-1 (clone M1/70), biotin-conjugated anti-VCAM-1
(clone 429, MVCAM.A), PE-conjugated streptavidin, and PE Texas-
Red-conjugated streptavidin. For analyzing cultured cells by flow
cytometry, 7-AAD (BD Pharmingen) was always used to exclude
dead cells.
Flow cytometry analyses were conducted on a FACSCan, FACS-
Calibur, or FACSAria (Becton Dickinson & Co., Mountain View,
CA), and the data were analyzed with FlowJo software (Treestar,
San Carlos, CA).
Establishment of the Anti-Mouse TLR4 Monoclonal Antibody,
Clone UT49
A full description of the preparation and validation of this reagent will
be published elsewhere. Briefly, TLR4-deficient mice were intraper-
itoneally injected four times at 1 week intervals with 1 3 107 Ba/F3
cells expressing mouse TLR4 and mouse MD-2. Three days after
the last injection, mice were euthanized and spleens were removed.
Spleen cells were dispersed and fused with SP2/O cells by using
a standard fusion protocol with polyethylene glycol 1500 (Roche,
Basel, Switzerland). Hybridoma cells were selected in hypoxan-
thine/aminopterine/thymidine medium and screened by flow cytom-
etry with Ba/F3 cells expressing mouse TLR4-MD-2 complex and
parent Ba/F3 cells. Biotin-conjugated antibody was used for flow
cytometry.Isolation of Hematopoietic Stem and Progenitor Cells
Bone marrow cells were harvested and enriched for lineage-nega-
tive cells by incubation with antibody to CD11b/Mac-1 (clone M1/
70), anti-Ly6G (clone RB6-8C5), anti-CD45R (B220; clone RA3-
6B2), anti-CD19 (clone 1D3), and anti-TER119, followed by negative
selection with the MACS cell separation system (Miltenyi Biotec, Au-
burn, CA). For sorting of Flk-22 or Flk-2+ LKS+ (Lin2 IL-7Ra2 c-Kithi
Sca-1+), LKS2 (Lin2 IL-7Ra2 c-Kithi Sca-12), and CLP (Lin2 IL-7Ra+
c-Kitlo Sca-1lo), these partially lineage-depleted cells were further
stained with FITC-conjugated lineage markers: anti-CD2, anti-
CD33, anti-CD8a, anti-CD45R, anti-Ly6G, anti-CD11b/Mac-1, anti-
TER119, PE-conjugated IL-7Ra, APC-conjugated anti-c-Kit, PE-
Cy5-conjugated anti-Sca-1, and biotinylated anti-Flk-2 combined
with PE Texas-Red-conjugated streptavidin. For sorting of CMP
(Lin2 IL-7Ra2 c-Kithi Sca-12 CD34+ FcgR2/3lo), GMP (Lin2 IL-7Ra2
c-Kithi Sca-12 CD34+ FcgR2/3hi), and MEP (Lin2 IL-7Ra2 c-Kithi
Sca-12 CD342 FcgR2/3lo), the sorted LKS2 cells were further
stained with FITC-conjugated anti-CD34 and PE-conjugated anti-
FcgR2/3. Cells were sorted on a FACSAria (Becton Dickinson &
Co.) The sort gates and the post-sort analyses are illustrated in
Method 1 in the Supplemental Data.
Serum-free, Stromal Cell-free Cell Cultures
Round-bottomed, 96-well plates or flat-bottomed, 24-well plates
(Corning, Inc.) were used for these cultures. Sorted cells were cul-
tured with X-VIVO15 medium (Biowhittaker, Walkersville, MD) or
StemPro-34 SFM medium (Invitrogen, Carlsbad, CA). X-VIVO15 me-
dium, which seemed to be optimal for lymphoid cultures, contained
1% detoxified bovine serum albumin (Stem Cell Technologies,
Vancouver, Canada), 5 3 1025 M 2-mercaptoethanol (2-ME), 2 mM
L-glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin.
StemPro-34 SFM medium containing 2 mM L-glutamine, 100 U/ml
penicillin, and 100 mg/ml streptomycin was usually used for myeloid
cultures. The concentrations of cytokines were IL-7, 1 ng/ml; FL, 100
ng/ml; SCF, 20 ng/ml, M-CSF, 20 ng/ml; GM-CSF, 20 ng/ml. The cells
were incubated at 37ºC in a humidified atmosphere of 5% CO2 in air.
Single Cell Culture on OP9 Stromal Cells
Sorted CLPs were cultured with X-VIVO15 in the presence of SCF (20
ng/ml), FL (100 ng/ml), and IL-7 (1 ng/ml) with or without LPS (10 mg/
ml) or Pam3CSK4 (1 mg/ml). After 24 hr, cultured cells were harvested
and washed with medium three times. A single cell sorting for the
cultured cells was then conducted on a FACSAria, and a single
cell was plated on OP9 stromal cells in a 96-well plate and cultured
for 10 days in the presence of SCF (20 ng/ml), FL (100 ng/ml), and IL-
7 (1 ng/ml). The conditioning medium for OP9 was MEMa medium
(Invitrogen), containing 20% FCS, 5 3 1025 M 2-ME, 2 mM L-gluta-
mine, 100 U/ml penicillin, and 100 mg/ml streptomycin. Positive
wells (more than 30 cells) were determined by microscopic observa-
tion. Cells were harvested and then stained with mAbs to CD19,
CD11c, and Mac-1 and were analyzed by flow cytometry. Cells
were also stained with a mAb to VCAM-1 to exclude stromal cells.
The OP9 stromal cell line was kindly provided by Dr. Shin-Ichi Hay-
ashi (Tottori University, Japan).
In Vitro BrdU Incorporation
Sorted Flk-22 LKS+ cells (10,000 cells/well) were cultured with or
without LPS (10 mg/ml) or Pam3CSK4 (1 mg/ml) in the presence of
SCF (20 ng/ml) for 50 hr and were pulsed with 10 mM 5-bromo-20-de-
oxyuridine (BrdU) for the final 18 hr. The cells were then stained with
anti-BrdU. A BrdU flow kit was purchased from BD Pharmingen.
Analyses by flow cytometry were conducted on a FACSCan.
Interaction of LPS with the TLR4-MD-2 Complex
Whole bone marrow cells from C57BL/6 mice were cultured in
RPMI1640 medium (Mediatech, Inc., Herndon, VA) containing 10%
FCS, 5 3 1025 M 2-ME, 2 mM L-glutamine, 100 U/ml penicillin, and
100 mg/ml streptomycin and were stimulated with or without 1 mg/
ml LPS for 1 hr. Then, cells were harvested and stained with mAbs
to TLR4-MD-2, Mac-1, lineage markers (CD2, CD3e, CD8a,
CD45R/B220, CD11b/Mac-1, Ly6G, TER119), Sca-1, and c-Kit. Alter-
natively, C57BL/6 mice were intravenously or intraperitoneally in-
jected with PBS or 100 mg LPS. After 1 hr, whole bone marrow cells
were harvested from femurs and tibiae and stained with mAbs to
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reagent is unique in detecting a conformation-dependent epitope on
TLR4-MD-2 (Akashi et al., 2003).
Cell Morphology
Cytospins of cultured progenitor cells were stained with Giemsa-
May-Gru¨nwald (Sigma Diagnostics, St. Louis, MO), mounted in Im-
mersol (Zeiss, Thornwood, NY), and analyzed in the OMRFs Biolog-
ical Imaging Facility on a Zeiss Axioplan 2i microscope with a 1003/
1.4 NA Plan Achromat objective. Photomicrographs were made with
an AxioCam MRc color camera (Zeiss) and AxioVision 3.1 software
(Zeiss).
Semiquantitative RT-PCR Analysis of Gene Expression
The mRNAs were isolated from sorted cells by using MicroPoly(A)
Pure (Ambion, Austin, TX). The cDNAs were then prepared from DN-
ase I-treated mRNA by using oligo-dT and Moloney murine leukemia
virus reverse transcriptase (Invitrogen). PCR reactions were con-
ducted in buffer containing 200 mM dATP, dGTP, dTTP; 100 mM
dCTP; and 0.5 mCi [a-32P]dCTP. Aliquots were removed at cycles
25, 28, and 31 for b-actin and cycles 32, 35, and 38 for all others to
insure that PCR remained within the exponential range of amplifica-
tions. Aliquots (5 ml) were denatured in a formamide-loading buffer
and applied to a 6% polyacrylamide gel containing 7 M urea. Incor-
poration of [a 32P] dCTP into PCR product bands was quantified by
PhosphoImager (Molecular Dynamics, Sunnyvale, CA). The primer
sequences for each gene are given in Method 2 in the Supplemental
Data.
Statistical Analysis
The statistical significance of differences between group means was
determined with the Student’s t test. p values less than 0.05 were
considered significant.
Supplemental Data
Supplemental Data include seven additional figures, Method 1, and
Method 2 and are available at http://www.immunity.com/cgi/
content/full/24/6/801/DC1/.
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